Fig. 2From: A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trialTmax images on D0 (a) with relevant DWI (b) and FLAIR lesions on D3 (c) and FLAIR lesions on D9 (d) from patients 1 and 5Back to article page